Details of the Drug Reposition
General Information of This Drug (ID: DM5I2CC)
| Drug Name | ||||||
|---|---|---|---|---|---|---|
| Synonyms | copper(II)-ATSM; Copper(II)-diacetyl-di(N4-methylthiosemicarbazone); Cu-ASTM; Cu-diacetyl-bis(N4-methylthiosemicarbazonate); diacetylbis(N(4)-methylthiosemicarbazonato) copper(II) | |||||
Information on Drug Reposition of This Drug
| Molecular Interaction Atlas (MIA) | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1 Phase 1/2 Indication(s)
|
|
|||||||||||||||||||||||||
|
1 Phase 1 Indication(s)
|
|
|||||||||||||||||||||||||
